PALISADE BIO INC (PALI)
US6963894026 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.30M | -14.26M | -26.62M | -16.27M | -8.35M | |||
| Depreciation Amortization | 4.00K | 0.00 | 0.00 | 90.00K | 140.00K | |||
| Change In Working Capital | 400.00K | 1.25M | -4.76M | 950.00K | 210.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 763.00K | -350.00K | 16.60M | 6.20M | 740.00K | |||
| OPERATING CASH FLOW | -11.13M | -13.36M | -14.77M | -9.03M | -7.26M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.00K | -10.00K | N/A | N/A | 0.00 | |||
| Other Investing Activity | N/A | 0.00 | -50.00K | N/A | 0.00 | |||
| INVESTING CASH FLOW | -4.00K | -10.00K | -50.00K | N/A | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -391.00K | -790.00K | -180.00K | -230.00K | 40.00K | |||
| Stock Issued/Repurchased | 12.19M | 16.68M | 25.01M | 14.70M | 6.55M | |||
| Other Financing Activity | -617.00K | -630.00K | -220.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 11.19M | 15.26M | 24.61M | 14.47M | 6.59M | |||
| Exchange Rate Effect | N/A | N/A | N/A | 0.00 | -10.00K | |||
| CHANGE IN CASH | 49.00K | 1.89M | 9.79M | 5.44M | -680.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.13M | -13.36M | -14.77M | -9.03M | -7.26M | |||
| Capital Expenditure | -4.00K | -10.00K | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -11.14M | -13.37M | -14.77M | -9.03M | -7.26M | |||
All data in USD